Royalty Pharma Cash from Investing (TTM) Trends

Royalty Pharma PLC (RPRX)

28.02 +0.04 (+0.14%) USD | NASDAQ | Apr 25, 12:58

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	-2.073B
September 30, 2023	-657.88M
June 30, 2023	-1.632B
March 31, 2023	-1.599B
December 31, 2022	-1.029B
September 30, 2022	-1.996B
June 30, 2022	-1.416B
March 31, 2022	-1.260B
December 31, 2021	-1.870B

Date	Value
September 30, 2021	-2.151B
June 30, 2021	-2.226B
March 31, 2021	-2.597B
December 31, 2020	-2.759B
September 30, 2020	-1.990B
June 30, 2020	-1.685B
March 31, 2020	-1.598B
December 31, 2019	-2.154B

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-2.759B

Minimum

Dec 2020

-657.88M

Maximum

Sep 2023

-1.805B

Average

-1.870B

Median

Dec 2021

Cash from Investing (TTM) Benchmarks